Lipella Pharmaceuticals Inc. Operating Cash Flow
Lipella Pharmaceuticals Inc. (LIPO) reported Operating Cash Flow of -$3.79 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2025-11-14
- Lipella Pharmaceuticals Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$926.06K.
- Lipella Pharmaceuticals Inc. net cash provided by (used in) operating activities for the quarter ending 2025-06-30 was -$1.43M.
- Lipella Pharmaceuticals Inc. net cash provided by (used in) operating activities for the quarter ending 2025-03-31 was -$1.43M.
- Lipella Pharmaceuticals Inc. net cash provided by (used in) operating activities for the quarter ending 2024-12-31 was -$990.41K.
- Lipella Pharmaceuticals Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$3.95M.
- Lipella Pharmaceuticals Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$3.15M.
- Lipella Pharmaceuticals Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$1.83M.
- Lipella Pharmaceuticals Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$989.27K.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2025-09-30 | -$926.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$2.36M derived: sum of 2 quarters · filed 2025-11-14 | -$3.79M 10-Q · filed 2025-11-14 | -$4.78M derived: sum of 4 quarters · filed 2025-11-14 | |
| 2025-06-30 | -$1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$2.86M 10-Q · filed 2025-08-14 | -$3.85M derived: sum of 3 quarters · filed 2025-08-14 | -$4.50M derived: sum of 4 quarters · filed 2025-11-14 | |
| 2025-03-31 | -$1.43M 10-Q · filed 2025-05-14 | -$2.42M derived: sum of 2 quarters · filed 2025-05-14 | -$3.07M derived: sum of 3 quarters · filed 2025-11-14 | -$3.99M derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-12-31 | -$990.41K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$1.64M derived: sum of 2 quarters · filed 2025-11-14 | -$2.56M derived: sum of 3 quarters · filed 2025-11-14 | -$3.95M 10-K · filed 2025-03-28 | |
| 2024-09-30 | -$653.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$1.57M derived: sum of 2 quarters · filed 2025-11-14 | -$2.96M 10-Q · filed 2025-11-14 | -$3.69M derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | -$918.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$2.31M 10-Q · filed 2025-08-14 | -$3.03M derived: sum of 3 quarters · filed 2025-08-14 | -$3.72M derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | -$1.39M 10-Q · filed 2025-05-14 | -$1.39M 10-Q · filed 2024-05-09 | -$2.12M derived: sum of 2 quarters · filed 2025-05-14 | -$2.81M derived: sum of 3 quarters · filed 2025-05-14 | -$3.46M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | -$727.71K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$1.42M derived: sum of 2 quarters · filed 2025-03-28 | -$2.07M derived: sum of 3 quarters · filed 2025-03-28 | -$3.15M 10-K · filed 2025-03-28 | |
| 2023-09-30 | -$689.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$1.34M derived: sum of 2 quarters · filed 2024-11-14 | -$2.42M 10-Q · filed 2024-11-14 | -$2.65M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | -$655.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$1.73M 10-Q · filed 2024-08-13 | -$1.96M derived: sum of 3 quarters · filed 2024-08-13 | -$2.28M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | -$1.08M 10-Q · filed 2024-05-09 | -$1.31M derived: sum of 2 quarters · filed 2024-05-09 | -$1.63M derived: sum of 3 quarters · filed 2024-05-09 | -$2.21M derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | -$231.56K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$551.77K derived: sum of 2 quarters · filed 2024-02-27 | -$1.13M derived: sum of 3 quarters · filed 2024-02-27 | -$1.83M 10-K · filed 2024-02-27 | |
| 2022-09-30 | -$320.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$900.17K derived: sum of 2 quarters · filed 2023-11-14 | -$1.60M 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | -$579.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$1.28M 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | -$699.43K 10-Q · filed 2023-05-12 | ||||
| 2021-12-31 | -$989.27K 10-K · filed 2023-03-31 |